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Abstract
Although the majority of published cases of lead poisoning come from occupational exposures, some traditional
remedies may also contain toxic amounts of lead. Ayurveda is a system of traditional medicine that is native to
India and is used in many parts of world as an alternative to standard treatment regimens. Here, we report the
case of a 58-year-old woman who presented with abdominal pain, anemia, liver function abnormalities, and an
elevated blood lead level. The patient was found to have been taking the Ayurvedic medicine Jambrulin prior to
presentation. Chemical analysis of the medication showed high levels of lead. Following treatment with an oral
chelating agent, the patient’s symptoms resolved and laboratory abnormalities normalized. This case highlights the
need for increased awareness that some Ayurvedic medicines may contain potentially harmful levels of heavy
metals and people who use them are at risk of developing associated toxicities.
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Background
Ayurvedic medicine is a traditional system native to
India [1]. This system stresses the use of natural plant-
based medicines, and minerals including sulfur, arsenic,
lead, copper and gold are often added to formulations
with the belief that these metals are essential compo-
nents of vital molecules within the human body. In
India, over 100 colleges offer degrees in traditional
Ayurvedic medicine and in western countries, Ayurvedic
medicine is gaining popularity as complementary treat-
ment to modern medicine. Ayurvedic medicines are
used to treat a wide spectrum of diseases from head-
aches to cancer. Currently, the United States does not
specify a certification requirement for Ayurvedic practi-
tioners, although many training programs are being
offered through state-approved institutions. These prac-
titioners are able to prescribe the medications and
sometimes manufacture it themselves.
From 2000 to 2003, the Centers for Disease Control
reported 12 cases of lead poisoning in adults associated
with Ayurvedic medication intake occurring in five dif-
ferent states [2]. Some Ayurvedic preparations have
been found to contain contained lead and/or mercury at
100 to 10,000 times greater than acceptable limits [3].
Although not common in western societies, lead expo-
sure through dietary sources is a well-recognized phe-
nomenon and in past years, calcium supplements have
been a source of lead poisoning [4]. In addition to Ayur-
vedic medicine, other traditional medicines originating
from Asian, Middle Eastern and Hispanic cultures have
been found to contain lead and other heavy metals [5].
Although many health supplements are now subject to
limited government regulation in the U.S. through the
Dietary Supplement and Health Education Act of 1994,
these medicines are readily obtainable as herbal reme-
dies in health food stores and through the internet and
their safety and efficacy are not regulated by govern-
ment agencies such as the U.S. Food and Drug Adminis-
tration (FDA) [6]. Thus, without sufficient public
awareness, the risk of heavy metal exposure in indivi-
duals taking these supplements is quite high. Here, we
present a case of lead poisoning secondary to ingestion
of Indian Ayurvedic medicine, Jambrulin.
Case presentation
A 58-year-old woman from India residing in the U.S.
presented to the emergency department with a 10-day
history of progressively worsening post-prandial lower
abdominal pain and nausea accompanied by non-bilious
and non-bloody vomiting. She was in her usual state of
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any medium, provided the original work is properly cited.health prior to this illness. She had a past medical his-
tory of well-controlled non-insulin dependent diabetes
mellitus and hypertension. A recent colonoscopy was
unremarkable and she denied any history of melena or
bright red blood per rectum. Physical exam was notable
only for abdominal tenderness in the lower quadrants.
Laboratory studies revealed a normochromic normocytic
anemia with hemoglobin of 7.7 g/dL, hematocrit of
22.6%, MCV 87 fL and normal iron studies (Table 1). A
CT scan of the abdomen and pelvis showed no specific
abnormalities. The patient was discharged to home with
anti-emetics and instructions to follow up with her pri-
mary care physician.
Five days later, the patient returned to the emergency
department with worsening abdominal pain, nausea and
bilious vomiting. Physical exam was remarkable for dif-
fuse abdominal tenderness and pale conjunctivae.
Laboratory evaluation was notable for anemia with
hemoglobin of 8.8 g/dL, hematocrit of 23.5%, MCV of 87
fL and corrected reticulocyte count of 7%. The patient
was admitted and subsequently underwent extensive eva-
luation for gastrointestinal abnormalities including eso-
phagogastroduodenoscopy and colonoscopy, both of
which were unremarkable. Review of the peripheral
blood smear demonstrated normochromic, normocytic
anemia with extensive coarse basophilic stippling of the
erythrocytes (Figure 1). This triggered a screening for
heavy metals, which revealed an elevated blood lead level
(BLL) of 102 μ g/dL (normal < 10 μ g/dL). Zinc protopor-
phyrin (ZPP) was subsequently found to be elevated at
912 μ g/dL (normal < 35 μ g/dL). The clinical picture
was consistent with lead poisoning. Upon further ques-
tioning, the patient disclosed that she had been taking an
Indian Ayurvedic medicine called Jambrulin. The patient
had obtained the medication from Unjha pharmacy
through a family member in India. She had been taking 2
pills daily over a period of 5 to 6 weeks in an effort to
enhance control of her diabetes. She stopped taking the
medication approximately 2 weeks prior to admission
because of the abdominal pain.
The patient was instructed not to take Jambrulin and
was started on dimercaptosuccinic acid (DMSA), an oral
lead chelator at a dose of 10 mg/kg three times a day
for five days followed by 10 mg/kg twice a day for two
weeks. At the end of chelation therapy, her BLL
decreased to 46 μg/dL, with improvement of her anemia
and resolution of her abdominal pain (Figure 2 and
Table 1). Of note, the patient’s sister and brother had
also been taking the same medication prior to our
patient’s diagnosis. They were subsequently found to
have BLLs of 100 and 51 μg/dL, respectively and were
advised to discontinue the supplement.
Examination of the remaining medication from the
patient revealed 1.25 × 1.0 cm ovoid black pills (Figure
3A). In addition, a radiographic study of the Jambrulin
pills showed them to be diffusely opaque, containing
flakes of high attenuating material, consistent with the
presence of lead or other heavy metals (Figure 3B). One
of the Jambrulin pills was crushed and solubilized in
nitric acid and lead content was measured after serial
10-fold dilutions using a LeadCare II Blood Lead Test
System as well as graphite furnace atomic absorption
spectrophotometry. The pill tested was found to contain
approximately 21.5 mg of lead. The pills were also sent
to the Connecticut Department of Public Health Adult
Blood Lead Epidemiology and Surveillance Program and
Public Health Laboratory and were found to contain
approximately 3.5% lead by weight or 35,000 μg/g.
Discussion and Conclusion
Exposure to lead through ingestion or inhalation can
occur from contaminated air, water, soil, food, and con-
sumer products. One of the largest threats to children is
lead-based paint that exists in many homes, especially
those built in the U.S. before 1978. Occupational expo-
sure is currently the most common cause of lead poi-
soning in adults. Findings of National Health and
Nutrition Examination Surveys indicate that BLLs are in
a continuous decline in all age groups and racial/ethnic
populations [7]. Nonetheless, toxic exposure to lead
Table 1 Laboratory values
Lab values (Reference) First emergency room visit On admission End of chelation
Hemoglobin (12-16 g/dL) 7.7 8.2 12.2
Hematocrit (37-47%) 22.6 23.5 36.4
Lead level (< 10 μ g/dL) ND 102 46
Reticulocyte count (0.6-2.7) ND 13.9 12.1
ZPP (15-36 μg/dL) ND 912 ND
Total bilirubin (< 1.20 mg/dL) 1.34 1.35 0.66
AST (0-34 U/L) 34 54 30
ALT (0-34 U/L) 45 90 40
Abbreviations: ZPP, zinc protoporphyrin; ND, not done
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poorly recognized public health problem.
Lead is stored in the blood, bone and soft tissues
including the brain, spleen, kidneys, liver, and lungs.
Like many other heavy metals, presence of excess levels
of lead leads to production of free radicals which subse-
quently causes oxidative damage of cellular components
including DNA and cell membranes [8]. Lead interferes
with DNA transcription, enzymatic synthesis of vitamin
D, and enzymes that maintain the integrity of the cell
membranes. As an electropositive metal, lead has high
affinity for negatively charged sulfhydryl groups resulting
in denaturation of enzymes such as delta-aminolevulinic
acid dehydratase (ALA-D) and ferrochelatase, both of
which are important for heme synthesis. The disruption
of heme synthesis leads to the accumulation of free ery-
throcyte protoporphyrins. Anemia often develops at very
high BLLs (usually > 80 μg/dL). Inhibition of pyrimidine
5’-nucleotidase can prevent the degradation of ribosomal
RNA in red blood cells leading to basophilic stippling
on a peripheral smear, a classic finding which can be
apparent at BLLs of ~50 μg/dL [9].
Currently, there are over 600 different Ayurvedic pre-
parations that are manufactured for children and adults
as herbal remedies to treat a wide range of illnesses
including the common cold, diabetes, infertility,
Figure 1 Wright-Giemsa stained smear of peripheral blood. Coarse basophilic stippling of the erythrocytes results from the poisoning of the
5’ nucleotidase normally responsible for degrading RNA. Magnification is 1000x.
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corresponds to day -4; the day of admission during the second emergency room visit is designated as day 1.
Figure 3 Jambrulin tablets. A. The tablets are 1.25 cm black, ovoid pills (ruler is in cm). B. X-ray shows diffusely opaque Jambrulin pills with
flakes of high attenuating material.
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tory problems, rashes, and pain [3,10,11]. A comprehen-
sive analysis of 193 Ayurvedic medications revealed the
presence of heavy metals in ~20% of products analyzed
[3]. Although lead was the most commonly detected
heavy metal, many products also contained significant
amounts of mercury and arsenic. Many of these medica-
tions are manufactured both in India and in the U.S. As
they are marketed as supplements, they are not regu-
lated by the U.S. FDA and are readily available in health
food stores as well as over the internet.
Symptoms of adult lead poisoning are variable and
include abdominal pain, nausea, constipation, anorexia,
fatigue, decreased libido, headache, irritability, arthral-
gias, myalgias, anxiety and neurologic dysfunction ran-
ging from subtle cognitive deficits to a predominantly
motor peripheral neuropathy to encephalopathy. Some
of these symptoms, especially the neurological symp-
toms, may be irreversible. The symptoms of lead toxicity
usually appear at a BLLs of 40-60 μg/dL in adults [12].
Over the last 25 years, numerous cases of lead toxicity
associated with Ayurvedic medicine have been reported
i nt h el i t e r a t u r e( T a b l e2 ) .A l t h o u g ht h ec o m m o n
denominator was the intake of Ayurvedic preparations,
patients were taking these medications for a wide range
of indications. The vast majority of individuals presented
with gastrointestinal symptoms including abdominal
pain, nausea, vomiting, anorexia and constipation and of
them were found to have elevated BLLs. Managements
varied widely and included oral chelation with D-peni-
cillamine or DMSA or intravenous infusions of Ca-
EDTA, Na-EDTA, or dimercaprol. In some instances,
combination therapy was administered. The current
reference range for acceptable BLLs in healthy indivi-
duals without excessive exposure to environmental
sources of lead is < 10 μ g/dL for children and < 25 μ
g/dL for adults [3]. To date, there are no clinical trials
that define the optimal management although it is gen-
erally accepted that the first step is to identify and
remove the source of the exposure. Chelation therapy
should be initiated when the BLL is > 80 μ g/dL in
asymptomatic and > 50 μ g/dL in symptomatic adults
and should be continued until the BLL is < 50 μ g/dL.
In the case presented here, timely diagnosis and iden-
tification of source of exposure were critical in prevent-
ing the long-term consequences of lead poisoning. Both
the FDA and the Connecticut Department of Public
Health were notified and several additional cases of lead
Table 2 List of reported cases of lead toxicity associated with Ayurvedic mediation
1
Reference Ayurvedic Medicine Age Sex Indication Symptoms Hgb
(g/dL)
BLL
(μg/dL)
Management
[2] NR
2 31 F Fertility Abdominal pain, nausea,
spontaneous abortion
NR 112 Oral chelation
3
[2] Jambrulin 50 M Diabetes NR NR 92 Oral chelation
3
[2] Jambrulin 40 F Diabetes NR NR 92 Oral chelation
3
[13] NR 28 M Weakness Intestinal obstruction 8 145 Oral D-penicillamine
[14] NR 23 M NR Anorexia, abdominal pain, weight
loss
9.4 56 Ca -EDTA infusion
[15] Vatyog Sahacharadi
Gandharvahastadi
28 M Back pain Abdominal pain, constipation NR 70 Oral DMSA
[16] NR 58 M Weakness Paresthesias 14.3 74 Oral D-penicillamine
[17] Guglu 41 M Hypertension Memory loss, anorexia, anhedonia NR 161 Dimercaprol infusion
[18] NR 51 F Dengue fever Memory loss, nausea, abdominal
pain
NR 69 None
[19] NR 24 M Erectile
dysfunction
Autonomic dysfunction, pseudo
obstruction
NR 99 Oral DMSA
[20] Multiple Ayurvedic
medications
4
39 F Muscular
dystrophy
Weakness, anorexia, constipation,
back pain
7.9 88 Na-EDTA infusion and
oral DMSA
[21] Multiple Ayurvedic
medicines
4
35 F NR Abdominal pain, constipation,
vomiting
8.3 140 Ca-EDTA infusion and
oral DMSA
[22] Multiple Ayurvedic
medicines
4
45 M Anxiety Weakness, vomiting and
abdominal pain
14.2 122 Oral D-penicillamine
[22] Gulkand 36 F Psoriasis Insomnia, headache, abdominal
pain, joint pain
8 115 Ca-EDTA infusion
[22] Chandraprabhavati EVR 46 M Hand
weakness
Abdominal pain NR 42 None
1Cases that did not report BLL were excluded.
2Not reported.
2Oral chelation therapy was reported but specifics were not provided.
4Multiple medications were
given but names were not provided.
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supplement. Despite the body of literature on this topic,
lead poisoning through herbal supplements still remains
a public health problem. Relatively few health care prac-
titioners are familiar with the traditional medicines and
health practices and most patients are unaware of the
contents of herbal medications as well as the potential
consequences of consuming these agents. Since patients
often do not discuss the use of traditional medicines or
herbal supplements, it is the responsibility of physician
to obtain a detailed history of medications. Additional
guidelines regulating the quality of dietary supplements
are needed. Enhancing public awareness about the
harmful effects of the seemingly innocuous herbal sup-
plements is essential for the prevention of heavy metal
poisoning.
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